Femtobiomed Inc
327610
Company Profile
Business description
Femtobiomed Inc is a South Korea based company engaged in developing a cargo-free intracellular delivery platform called Cell Shot Platform. It is focused on using this technology to work on cell-based therapeutic pipelines.
Contact
17 Pangyo-ro 228 (ibaegisippal) beo
Sampyeong-dong, Bundang-gu, Gyeonggi-do
Seongnam-si13487
KORT: +82 316228501
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
15
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,723.50 | 17.90 | -0.20% |
| CAC 40 | 7,575.99 | 22.54 | 0.30% |
| DAX 40 | 23,326.60 | 269.22 | 1.17% |
| Dow JONES (US) | 42,317.15 | 145.49 | 0.34% |
| FTSE 100 | 8,774.44 | 17.36 | -0.20% |
| HKSE | 23,530.48 | 292.74 | 1.26% |
| NASDAQ | 19,484.80 | 61.47 | -0.31% |
| Nikkei 225 | 38,403.23 | 85.11 | -0.22% |
| NZX 50 Index | 12,569.05 | 58.27 | -0.46% |
| S&P 500 | 5,982.33 | 1.46 | 0.02% |
| S&P/ASX 200 | 8,505.50 | 18.20 | -0.21% |
| SSE Composite Index | 3,359.90 | 2.21 | -0.07% |